Literature DB >> 22966249

Clinicopathological study of hepatocellular carcinoma with peliotic change.

Masaru Fujimoto1, Osamu Nakashima, Mina Komuta, Toshimitsu Miyaaki, Masamichi Kojiro, Hirohisa Yano.   

Abstract

Peliosis hepatis-like blood-filled cavities are frequently observed in the tumors of hepatocellular carcinoma (HCC). This finding is generally referred to as 'peliotic change' in HCC. However, the clinicopathological features of HCC with peliotic change (PHCC) are not fully understood. These issues are addressed in the present study. Among 294 consecutively surgically resected HCCs, the clinicopathological features of PHCC were compared with those of a common type of HCC (control). PHCC was observed in 116 (39.5%) of 294 HCCs. The mean tumor diameter of 3.4±0.9 cm of the PHCC group was significantly larger than that of the 2.5±0.9 cm of the control, and the incidence of PHCC was related to increased tumor diameter. In the 116 PHCCs, the tumors were completely or incompletely encapsulated. On ultrasonography, PHCCs showed hyperechoic and/or mosaic patterns. The mean diameter of 3.5±0.8 cm of PHCCs with a hyperechoic and/or mosaic pattern was significantly larger than that of 2.3±0.9 cm in the control. In conclusion, it is necessary for clinicians and pathologists to discern the characteristics of peliotic change as a morphological feature that modifies ultrasound findings.

Entities:  

Year:  2010        PMID: 22966249      PMCID: PMC3436385          DOI: 10.3892/ol_00000003

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

1.  Lipiodol accumulation in focal peliosis hepatis with sinusoidal dilatation.

Authors:  S G Shim; S W Paik; J G Hyun; M S Choi; J H Lee; P L Rhee; J J Kim; K C Koh; J C Rhee; K W Choi; C K Park
Journal:  J Clin Gastroenterol       Date:  2001-04       Impact factor: 3.062

2.  Peliosis of the liver in a patient with prostate carcinoma.

Authors:  A Drevelengas; D Chourmouzi; G Boulogianni
Journal:  JBR-BTR       Date:  2003 May-Jun

3.  Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.

Authors:  L Grazioli; G Morana; R Caudana; A Benetti; N Portolani; G Talamini; R Colombari; G Pirovano; M A Kirchin; A Spinazzi
Journal:  Invest Radiol       Date:  2000-01       Impact factor: 6.016

4.  A case of peliosis hepatis in association with tamoxifen therapy.

Authors:  G N Loomus; P Aneja; R A Bota
Journal:  Am J Clin Pathol       Date:  1983-12       Impact factor: 2.493

5.  Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.

Authors:  S Russmann; A Zimmermann; S Krähenbühl; B Kern; J Reichen
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

6.  Veno-occlusive disease and peliosis of the liver after thorotrast administration.

Authors:  A Dejgaard; K Krogsgaard; M Jacobsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

7.  Peliosis hepatis. Report of two autopsy cases with a review of literature.

Authors:  S Asano; H Wakasa; S Kaise; T Nishimaki; R Kasukawa
Journal:  Acta Pathol Jpn       Date:  1982-09

8.  Peliosis hepatis. Report of nine cases.

Authors:  T Karasawa; T Shikata; R D Smith
Journal:  Acta Pathol Jpn       Date:  1979-05

9.  Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma.

Authors:  K Sugimachi; S Tanaka; K Taguchi; S Aishima; M Shimada; M Tsuneyoshi
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

10.  Peliosis hepatis in the acquired immunodeficiency syndrome.

Authors:  C A Czapar; C M Weldon-Linne; D M Moore; D P Rhone
Journal:  Arch Pathol Lab Med       Date:  1986-07       Impact factor: 5.534

View more
  6 in total

Review 1.  General Pitfalls in Imaging of Patients With Cirrhosis.

Authors:  Ali Morshid; Victoria Chernyak; Alice W Fung; Khaled Elsayes
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

2.  Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Seo-Youn Choi; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim; Soohyun Ahn; Hyeon Seon Ahn
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

3.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

4.  Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.

Authors:  Seo-Youn Choi; Young Kon Kim; Ji Hye Min; Tae Wook Kang; Woo Kyoung Jeong; Soohyun Ahn; Hojeong Won
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

Review 5.  Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Authors:  Michael S Torbenson
Journal:  Hum Pathol       Date:  2020-12-30       Impact factor: 3.526

6.  Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma.

Authors:  Khushboo Gala; John Guardiola-Bright; Suzanne McGee
Journal:  Cureus       Date:  2020-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.